Roche registers giredestrant Phase 3 trial; six other studies updateNov 6Weekly roundup, 16 itemsAbbViealectinibUpdated
GeoVax files for $5 million offering as Xbrane's ranibizumab approval standsNov 3Regulatory decisionGeoVax Labs, Inc.ranibizumab
Genentech lists Phase Ib KRAS G12D trial; Roche-sponsored DLBCL study shows updateOct 9Weekly roundup, 9 itemsalectinibcisplatinUpdated
Bayer posts Phase 3 gadoquatrane brain/spine MRI results; ARI2 Eylea data remain on fileOct 8Weekly roundup, 2 itemsafliberceptBayerUpdated
Samsung Bioepis gets label supplement approved for Byooviz ranibizumab biosimilarSep 1Regulatory decisionBiogenHarrow Inc
Outlook Therapeutics posts Phase 3 results for ONS-5010 in wet AMD trialAug 3Trial updatebevacizumabOutlook Therapeutics, Inc.
Outlook Therapeutics posts NORSE EIGHT phase 3 results for ONS-5010 in wet AMDJun 30Trial updatebevacizumabOutlook Therapeutics, Inc.